Literature DB >> 16052627

Human Plasma PeptideAtlas.

Eric W Deutsch1, Jimmy K Eng, Hui Zhang, Nichole L King, Alexey I Nesvizhskii, Biaoyang Lin, Hookeun Lee, Eugene C Yi, Reto Ossola, Ruedi Aebersold.   

Abstract

Peptide identifications of high probability from 28 LC-MS/MS human serum and plasma experiments from eight different laboratories, carried out in the context of the HUPO Plasma Proteome Project, were combined and mapped to the EnsEMBL human genome. The 6929 distinct observed peptides were mapped to approximately 960 different proteins. The resulting compendium of peptides and their associated samples, proteins, and genes is made publicly available as a reference for future research on human plasma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16052627     DOI: 10.1002/pmic.200500160

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  53 in total

1.  Simultaneous quantification of apolipoprotein A-I and apolipoprotein B by liquid-chromatography-multiple- reaction-monitoring mass spectrometry.

Authors:  Sean A Agger; Luke C Marney; Andrew N Hoofnagle
Journal:  Clin Chem       Date:  2010-10-05       Impact factor: 8.327

Review 2.  Comparative human salivary and plasma proteomes.

Authors:  J A Loo; W Yan; P Ramachandran; D T Wong
Journal:  J Dent Res       Date:  2010-08-25       Impact factor: 6.116

Review 3.  The grand challenge to decipher the cancer proteome.

Authors:  Samir Hanash; Ayumu Taguchi
Journal:  Nat Rev Cancer       Date:  2010-09       Impact factor: 60.716

Review 4.  Proteomics: a pragmatic perspective.

Authors:  Parag Mallick; Bernhard Kuster
Journal:  Nat Biotechnol       Date:  2010-07-09       Impact factor: 54.908

Review 5.  Replacing immunoassays with tryptic digestion-peptide immunoaffinity enrichment and LC-MS/MS.

Authors:  Jessica O Becker; Andrew N Hoofnagle
Journal:  Bioanalysis       Date:  2012-02       Impact factor: 2.681

6.  Multiple-reaction monitoring-mass spectrometric assays can accurately measure the relative protein abundance in complex mixtures.

Authors:  Andrew N Hoofnagle; Jessica O Becker; Michael N Oda; Giorgio Cavigiolio; Philip Mayer; Tomas Vaisar
Journal:  Clin Chem       Date:  2012-02-03       Impact factor: 8.327

Review 7.  The blood peptidome: a higher dimension of information content for cancer biomarker discovery.

Authors:  Emanuel F Petricoin; Claudio Belluco; Robyn P Araujo; Lance A Liotta
Journal:  Nat Rev Cancer       Date:  2006-11-09       Impact factor: 60.716

8.  Solid-phase extraction of N-linked glycopeptides.

Authors:  Yuan Tian; Yong Zhou; Sarah Elliott; Ruedi Aebersold; Hui Zhang
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

Review 9.  Unleashing the power of proteomics to develop blood-based cancer markers.

Authors:  Ayumu Taguchi; Samir M Hanash
Journal:  Clin Chem       Date:  2012-10-24       Impact factor: 8.327

10.  The PeptideAtlas Project.

Authors:  Eric W Deutsch
Journal:  Methods Mol Biol       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.